YOUR DAILY PEPTIDE BRIEFING / SCIENCE / COMMUNITYNew source checks every six hours
Daily Peptide StackNEWS • RESEARCH • COMMUNITY
THE NEWS STACK / SOURCE NOTE

A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease.

A source-backed record from the peptide news monitor, with the original source linked below.

BEFORE YOU READ

This page links to the original record; it is not an independent analysis or clinical recommendation.

← Back to Trials Stack
Trials StackClinicalTrials.gov

A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease

Clinical trial record NCT07907965 was updated or published. See the registry for its current status, eligibility, and results (if reported).

Open original source ↗

Collected Oct 31, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.